Core Viewpoint - The company announced a delay in the project timeline for the "Medical Endoscope Production Base Construction Project" and an adjustment in the internal investment structure while maintaining the total amount and direction of the raised funds [1][5][7] Fundraising Overview - The company raised a total of RMB 750.15 million through an initial public offering, with a net amount of RMB 659.18 million after deducting issuance costs [1][2] - The funds are stored in a dedicated account, and the company has signed regulatory agreements with relevant parties [2] Use of Funds - As of the end of the reporting period, RMB 544.86 million has been invested in the "Medical Endoscope Production Base Construction Project," out of a planned total investment of RMB 640 million [2][3] Project Delay Details - The project completion date has been extended to August 2026 due to construction delays caused by adjustments in production layout and external engineering approvals [3][4] - The company is actively working to expedite the project construction [4] Internal Investment Structure Adjustment - The internal investment structure for the project has been optimized without changing the total investment amount, with adjustments made to construction and land costs while reducing equipment purchase and installation expenses [4][5] - The planned investment amounts remain unchanged for construction and working capital [5] Impact of Adjustments - The adjustments are expected to enhance the efficiency of fund utilization and align with the company's strategic development, without adversely affecting normal operations [5][6] - The company has followed necessary approval procedures in compliance with relevant regulations [6][7] Approval Process - The board and supervisory committee approved the adjustments during meetings held on August 27, 2025, with the matter pending shareholder approval [5][6]
澳华内镜: 关于部分募集资金投资项目延期及调整内部投资结构的公告